• GSK 2837808A for Reliable LDHA Assays

  2026-09-14

  A scenario-driven guide to using GSK 2837808A (SKU B4929) in viability, glycolysis, lactate, and glucose-consumption experiments. It separates validated LDHA evidence from hypothesis-generating colorectal cancer applications and provides practical guidance on formulation, controls, interpretation, and vendor selection.

• Deuterated Tetrazole CYP51 Inhibitor: V23 Findings

  2026-09-14

  The 2025 European Journal of Medicinal Chemistry study describes V23, a deuterated tetrazole CYP51 inhibitor designed to improve fungal selectivity, metabolic stability, and activity against resistant fungi. V23 combined broad in vitro antifungal activity, effects on fungal phase transformation and biofilms, low apparent cytotoxicity in tested cell lines, and significant in vivo efficacy, although its translational scope remains to be established.

• Clinically Safe Drugs and CRISPR Repair Choice

  2026-09-13

  This study screened 7,240 clinically relevant drug conditions in human induced pluripotent stem cells to identify compounds that redirect CRISPR-induced double-strand break repair toward NHEJ, MMEJ, or HDR. Its findings connect pharmacological perturbation with ESR2, AOX1, ATM, and 53BP1 biology, while highlighting drug combinations with potential synthetic-lethal effects.

• Removing Pollen Interference in Bioaerosol EEM

  2026-09-12

  Zhang and colleagues developed a fluorescence-data workflow that reduces pollen interference when hazardous biological substances are classified by excitation–emission matrix spectroscopy. Combining spectral transformations with random forest classification improved recognition of the evaluated sample set and offers a practical direction for rapid bioaerosol screening.

• Resazurin Cell Viability Assay Kit for ROS Studies

  2026-09-11

  Turn metabolic activity into a sensitive, scalable readout for drug response, proliferation, and cytotoxicity studies. The Resazurin Cell Viability Assay Kit is especially useful when researchers need a non-toxic fluorescence workflow that can be paired with apoptosis, ROS, mitochondrial, and gene-expression measurements.

• 6C Medium Extends Mouse Corneal Epithelial Proliferation

  2026-09-11

  An et al. developed a serum-free, feeder-free 6C culture system that preserves mouse corneal epithelial proliferative activity and limits epithelial–mesenchymal transition. The study links coordinated pathway modulation, including BMP receptor inhibition by LDN-193189, with improved progenitor-cell yields and faster epithelial wound repair in an experimental mouse model.

• HyperTrap Heparin HP Column for CSC Assays

  2026-09-10

  The HyperTrap Heparin HP Column enables selective biochemical enrichment of heparin-binding proteins relevant to cancer stem-cell assays. This article connects CCR7–Notch1 biology with practical fractionation, assay controls, and interpretation limits rather than treating affinity capture as a substitute for pathway validation.

• Dabigatran (Pradaxa): Mechanism & Assays

  2026-09-10

  Dabigatran, also known as Pradaxa, is a reversible direct thrombin inhibitor used in coagulation research and clinical anticoagulation. Its assay behavior, renal clearance, active metabolite, and formulation limits determine how results should be interpreted.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-09-09

  Build a quantitative delivery workflow that separates mRNA uptake from protein expression in the same sample. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines Cy5 tracking, EGFP translation, Cap1 chemistry, and 5-moUTP modification for nanoparticle screening and cell-targeting studies.

• Oteseconazole (VT-1161) in Candida Research

  2026-09-09

  Oteseconazole (VT-1161) combines potent fungal CYP51 inhibition with a practical profile for Candida susceptibility, resistance, biofilm, and translational studies. This workflow shows how to select concentrations, control solvent effects, interpret species-specific activity, and connect bench assays with recurrent vulvovaginal candidiasis research.

• PPACK Dihydrochloride: A Causal Assay Framework

  2026-09-08

  PPACK Dihydrochloride enables precise separation of thrombin-driven coagulation from purinergic platelet signaling. This article develops a causal assay framework grounded in the NF449 platelet study, helping researchers interpret thrombin inhibition assay and platelet aggregation inhibition data more rigorously.

• TRAP-1 Reactivates p53Y220C Through Induced Proximity

  2026-09-08

  The bioRxiv preprint reports TRAP-1, a chemical inducer of proximity that brings mutant p53Y220C into a ternary complex with BRD4 and restores transcriptional activity. In p53Y220C-expressing pancreatic cell lines, this mechanism rapidly induced p21 and other p53 target genes while suppressing cell growth, whereas control compounds unable to form the ternary complex lacked these effects.

• Merimepodib (VX-497): Practical IMPDH Workflows

  2026-09-07

  Merimepodib (VX-497) enables controlled interrogation of guanine-nucleotide metabolism in antiviral, immunology, and oncology assays. This guide translates IMPDH biology and recent PEDV findings into practical dosing, rescue, readout, and troubleshooting strategies.

• Methylprednisolone Workflows for Inflammation Models

  2026-09-07

  Methylprednisolone provides a controlled glucocorticoid perturbation for cytokine, macrophage, and bone-injury studies. This guide connects in vitro anti-inflammatory assays with a glucocorticoid-induced osteonecrosis workflow while emphasizing formulation control, orthogonal endpoints, and practical troubleshooting.

• BCECF-AM for Intracellular pH Measurement

  2026-09-05

  BCECF-AM is a cell membrane permeable dye and intracellular esterase substrate used for ratiometric intracellular pH measurement. Its 490/440 excitation approach can report pH-sensitive fluorescence, but plant vacuolar acidification requires compartment-specific validation.

8468 records 1/565 page Next 12345 下5页 Last page